Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael D. Otremba, M.D.

Concepts (75)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cranial Fossa, Anterior12013130.440 Why?
Hospital Charges120153510.430 Why?
Prisons120151780.420 Why?
Otitis12012210.400 Why?
Mastoiditis12012380.390 Why?
Parathyroid Glands220245220.380 Why?
Agammaglobulinemia120121740.350 Why?
Maxilla120134890.340 Why?
Skull Base Neoplasms120132810.330 Why?
Antibodies, Monoclonal, Murine-Derived120126950.310 Why?
Immunoglobulins, Intravenous120126720.280 Why?
Poverty1201527190.210 Why?
Hypocalcemia120242030.210 Why?
Developing Countries1201529010.200 Why?
Thyroidectomy220249150.190 Why?
Neoplasms, Unknown Primary120181010.140 Why?
Neck Dissection120182010.130 Why?
Radiotherapy, Adjuvant2201817940.130 Why?
Papillomavirus Infections2201816370.130 Why?
Thyroid Gland1202211720.130 Why?
Patient Credit and Collection12015160.130 Why?
Salivary Gland Neoplasms120183060.120 Why?
Head and Neck Neoplasms2201829150.110 Why?
Carcinoma, Squamous Cell2201840830.100 Why?
Human Rights120153120.100 Why?
Oropharyngeal Neoplasms120174930.100 Why?
Lymph Node Excision1201812760.100 Why?
Parotid Neoplasms120131580.090 Why?
Lymphatic Metastasis1201829300.090 Why?
Chemotherapy, Adjuvant1201835500.080 Why?
Neoplasm, Residual1201310140.070 Why?
SEER Program1201314760.070 Why?
Lymphoma1201319070.060 Why?
Immunologic Factors1201216000.050 Why?
Antirheumatic Agents1201213740.050 Why?
Kaplan-Meier Estimate3201865370.050 Why?
Parathyroidectomy120222440.040 Why?
Spectroscopy, Near-Infrared120247520.040 Why?
Neoplasm Staging32018112490.040 Why?
Chronic Disease1201293790.030 Why?
Arthritis, Rheumatoid1201237620.030 Why?
Drug Therapy120175040.030 Why?
Neoplasm Recurrence, Local1201394250.030 Why?
Treatment Outcome32018654080.030 Why?
Humans1020247683690.030 Why?
Survival Rate22018128750.020 Why?
Prognosis32018300310.020 Why?
Papillomaviridae1201711350.020 Why?
Proportional Hazards Models22018125610.020 Why?
Female620183969260.020 Why?
Middle Aged520182234060.020 Why?
Propensity Score1201819700.020 Why?
Follow-Up Studies12012394290.020 Why?
Tomography, X-Ray Computed12013207630.020 Why?
Young Adult22013600380.020 Why?
Retrospective Studies42018818350.020 Why?
Sex Distribution1201322860.020 Why?
Randomized Controlled Trials as Topic12024103580.020 Why?
Age Distribution1201328810.020 Why?
Male520183647610.020 Why?
Combined Modality Therapy1201885590.020 Why?
Magnetic Resonance Imaging12013368400.020 Why?
Survival Analysis12018101270.020 Why?
Aged420181715140.010 Why?
Disease-Free Survival1201368560.010 Why?
Postoperative Complications12024158790.010 Why?
Incidence12013215520.010 Why?
Infant, Newborn12013263940.010 Why?
Infant12013364960.010 Why?
Child, Preschool12013426200.010 Why?
Aged, 80 and over12013596790.000 Why?
United States12013731200.000 Why?
Child12013808560.000 Why?
Adolescent12013891630.000 Why?
Adult120132235280.000 Why?
Otremba's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (75)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.